ELANE p.Ala61Glu
c.182C>A · rs137854447 · VCV2037000
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3191 | likely benign |
|---|---|---|
| REVEL | 0.52 | indeterminate |
| SaProt | LLR -9.40 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.1 | GERP -0.046, phastCons 0.003 |
| Regional constraint | o/e 1.04 | unconstrained · MANE · 3,171 bp · p 0.52 · regional, not allelic |
| Overall | ||
| CADD | 17.28 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ELANE
- Protein
- p.Ala61Glu
- Coding
- c.182C>A
- MANE Select
- NM_001972
- dbSNP
- rs137854447
- Type
- single nucleotide variant
- Location
- chr19:852990 (GRCh38)
- Gene constraint
- LOEUF 1.245 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 88.42 · 38 PDB
- Residue 61
- a disulfide bond; a β-strand; the peptidase s1 domain; a UniProt-annotated variant site (sequence variant); a UniProt-annotated variant site (in scn1 and ch)
Disease context
cyclic neutropenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: neutropenia, severe congenital, 1, autosomal dominant
For Cyclic neutropenia (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- ELANE p.Ala61Val Pathogenic/Likely pathogenic ★★ ⚠ same residue
- ELANE p.Ala61= Likely benign ★ same residue
- ELANE c.597+1G>A Pathogenic ★★ same condition
- ELANE c.597+1G>C Pathogenic ★★ same condition
- ELANE c.597+1G>T Pathogenic ★★ same condition
- ELANE c.597+5G>A Pathogenic/Likely pathogenic ★★ same condition
- ELANE p.Ala57Thr Pathogenic/Likely pathogenic ★★ same condition
- ELANE p.Arg103Pro Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elane-p-ala61glu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown